Life Sciences Snapshot – Q4 2024 – A Quarterly Report on Financing Trends
14 minute read | December.20.2024
Partner
Washington, D.C.
Georgia Ravitz focuses on matters before the FDA, counseling U.S. and international life science, healthtech and consumer product clients through all phases of the product lifecycle including strategic pre-market regulatory counseling, promotions and advertising, and post-market regulatory compliance.
Georgia also has extensive experience in assisting clients with product recalls, crisis management and government enforcement. Her practice in this sector includes assisting manufacturers, distributors, retailers and importers on all types of FDA regulated products including pharmaceuticals, medical devices and software, wearables, health and wellness products, cosmetics, cell and plant based foods, conventional foods, ag tech, compounded drugs, and dietary supplements.
Georgia’s deep experience and ability to provide practical guidance in FDA and FDA-adjacent regulatory matters allows her to work closely with innovative companies looking to minimize regulatory burdens and maximize U.S. marketing opportunities in the life science and health tech industry verticals. She also conducts regulatory due diligence for private equity and public company transactions involving life science, medtech and innovative companies.
Georgia is a frequent speaker at conferences and events who contributes regularly to leading trade and consumer media outlets.
14 minute read | December.20.2024
2 minute read | October.10.2024
6 minute read | July.11.2024